Sandy Cove Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sandy Cove Advisors's AMGN Position: Q2 2026 in Review
Sandy Cove Advisors increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $10.6K and bringing the position to 1,578 shares worth $571K. The position accounts for 0.14% of the portfolio, ranked #82.
Sandy Cove Advisors first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.77M in Q3 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sandy Cove Advisors held 1,578 shares of Amgen worth $571K as of Q2 2026.
- Sandy Cove Advisors bought 31 Amgen shares in Q2 2026, an estimated $10.6K.
- Amgen made up 0.14% of Sandy Cove Advisors's portfolio in Q2 2026, its #82 holding.
- Sandy Cove Advisors first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Sandy Cove Advisors's Amgen position peaked at $1.77M in Q3 2023.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sandy Cove Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.